Association between Serum Sialic Acid Levels and Disease Severity in Psoriasis: A Case-control Study

Association between Serum Sialic Acid Levels and Disease Severity in Psoriasis: A Case-control Study

Introduction: Psoriasis is a chronic inflammatory disease distributed worldwide with varying prevalence among different geographical areas and ethnic groups. It has been recently found that oxidative stress is one of the important factors in the pathogenesis of psoriasis. The varied effects of oxida...

Full description

Bibliographic Details
Main Authors:	UG Bhavyashree, Laddha Vedant, B Vishal, Malcolm Pinto, Manjunath Shenoy
Format:	Article
Language:	English
Published:	JCDR Research and Publications Private Limited 2022-12-01
Series:	Journal of Clinical and Diagnostic Research
Subjects:	inflammatory disease immunogenicity psoriasis area severity index
Online Access:	https://www.jcdr.net/articles/PDF/17186/60052_CE(AD)_F[SH]_PF1(AG_OM)_PFA(SHU)_PB(AG_SHU)_PN(SHU).pdf

Similar Items

Evaluation of Serum 25-Hydroxy Vitamin D Levels in Premenapousal Psoriasis Patients
by: Meltem Vural, et al.
Published: (2014-12-01)

Comparative study of clinical and dermoscopic features in nail psoriasis
by: Naphisabet Wanniang, et al.
Published: (2020-01-01)

Circulating Irisin Levels in Patients with Chronic Plaque Psoriasis
by: Francesca Ambrogio, et al.
Published: (2022-08-01)

Assessment of Retinal Vasculature in Patients with Psoriasis
by: Alaa Laban, et al.
Published: (2022-11-01)

Role of osteopontin in psoriasis: An immunohistochemical study
by: M Yousry Abdel-Mawla, et al.
Published: (2016-01-01)

Psoriasis clearance rates with different treatments – An In-depth retrospective chart review
by: Katie Lovell, et al.
Published: (2023-01-01)

Life quality among psoriasis patients based on Dermatology Life Quality Index evaluation and its association with psoriasis severity in China: a cross-sectional study
by: Yiran Chen, et al.
Published: (2023-12-01)

Severity of periodontitis and salivary interleukin-1β are associated with psoriasis involvement
by: King-Jean Wu, et al.
Published: (2022-10-01)

Serum sE-selectin Levels in Newly Diagnosed Psoriasis Patients and Correlation with Psoriasis Area and Severity Index Score
by: Shveta, et al.
Published: (2017-11-01)

Tobacco smoking negatively influences the achievement of greater than three-quarters reduction in psoriasis area and severity index after eight weeks of treatment among patients with psoriasis: Findings from a prospective study
by: Yan Qiang*, et al.
Published: (2024-04-01)

Assessment of Vitamin D Level in Patients with Psoriasis and Its Correlation with Disease Severity: A Case–Control Study
by: Pokharel R, et al.
Published: (2022-09-01)

Study of serum Ceruloplasmin, Malondialdehyde (MDA) and hs-CRP as biomarkers of severity in Psoriasis
by: 1. K Prashanth, Assistant Professor, Department of Biochemistry, Rajiv Gandhi Institute of Medical Sciences [RIMS], Adilabad, Telangana State, India. 2. MohdInayatulla Khan, Assistant Professor, Department of Physiology, Rajiv Gandhi Institute of Medical Sciences [RIMS], Adilabad, Telangana State, India.
Published: (2020-12-01)

A 7-Year Retrospective Study of Narrowband Ultraviolet B Phototherapy for Psoriasis in Geriatric Patients
by: Lili Legiawati, et al.
Published: (2025-03-01)

Evaluation of Psoriasis Area and Severity Index as a Proxy for Biomarkers of Systemic Disease under Treatment with Tumour Necrosis Factor-alpha and Interleukin 12/23 Antagonists in Patients with Psoriasis: A Retrospective Cohort Study of 186 Treatment Cycles
by: Jochen H.O. Hoffmann, et al.
Published: (2021-05-01)

Evaluation of Serum Leptin Level in Psoriasis Patients and its Relation with the Severity of Disease
by: Mohammad Reza Sobhan, et al.
Published: (2023-09-01)

Correlation between disease severity, family income, and quality of life in psoriasis: A study from South India
by: Preethi B Nayak, et al.
Published: (2018-01-01)

Microbiota differences of skin and pharyngeal microbiota between patients with plaque and guttate psoriasis in China
by: Jingjin Hu, et al.
Published: (2022-08-01)

Clinical audit of methotrexate therapy in psoriasis at a tertiary care teaching hospital in Western India
by: Anuj Bhut, et al.
Published: (2023-01-01)

Efficacy and safety of isotretinoin in comparison to methotrexate in the patients suffering from moderate-to-severe plaque psoriasis: A prospective cohort study
by: Suhrita Paul, et al.
Published: (2022-04-01)

Assessment of Quality of Life in a Sample of Iraqi Patients with Psoriasis.
by: Sarah H. Abdulridha, et al.
Published: (2020-12-01)

A novel online calculator based on clinical features and hematological parameters to predict total skin clearance in patients with moderate to severe psoriasis
by: Yuxiong Jiang, et al.
Published: (2024-01-01)

Effect of Oral Drug Apremilast on Histopathological Changes in Patients of Plaque Psoriasis: A Prospective Observational Study
by: Yogendra Singh, et al.
Published: (2023-03-01)

Psoriasis: Not just skin deep
by: Malcolm Pinto, et al.
Published: (2015-01-01)

Population pharmacokinetic/pharmacodynamic analysis of AK111, an IL-17A monoclonal antibody, in subjects with moderate-to-severe plaque psoriasis
by: Qian Li, et al.
Published: (2022-08-01)

The Relationship Between Interatrial Block and PASI Score in Patients with Psoriasis
by: Nijad Bakhshaliyev, et al.
Published: (2021-03-01)

Association of serum calcium level and serum uric acid level in psoriasis and its correlation with severity of psoriasis
by: Jheel Ambike, et al.
Published: (2024-06-01)

CD19+ B cell subsets in the peripheral blood and skin lesions of psoriasis patients and their correlations with disease severity
by: J. Lu, et al.
Published: (2016-01-01)

Clinicoepidemiological profile of pediatric psoriasis: Experience from a tertiary care center
by: Vibhu Mendiratta, et al.
Published: (2023-01-01)

Evaluating Serum Levels of IL-33, IL-36, IL-37 and Gene Expression of IL-37 in Patients with Psoriasis Vulgaris
by: Mojtaba Sehat, et al.
Published: (2018-04-01)

Psoriasis: What Is New in Markers of Disease Severity?
by: Mircea Tampa, et al.
Published: (2024-02-01)

Interleukin-17 Inhibitor in Treatment of Psoriasis during COVID-19 Pandemic: An Ambispective Study
by: Ramesh Aravamudhan, et al.
Published: (2023-01-01)

Comparative Role of Topical Betamethasone Valerate with Topical Calcipotriol in Mild and Moderate Plaque Type Psoriasis
by: sana imran, et al.
Published: (2014-08-01)

Comparative Role of Topical Betamethasone Valerate with Topical Calcipotriol in Mild and Moderate Plaque Type Psoriasis
by: sana imran, et al.
Published: (2014-08-01)

Comparative Role of Topical Betamethasone Valerate with Topical Calcipotriol in Mild and Moderate Plaque Type Psoriasis
by: Sana Imran, et al.
Published: (2014-08-01)

Ocular manifestations of psoriasis: An inflammatory disease beyond the skin
by: Zeinab Aryanian, et al.
Published: (2023-01-01)

Role of Shear-Wave Elastography in Achilles Tendon in Psoriatic Arthritis and Its Correlation with Disease Severity Score, Psoriasis Area and Severity Index
by: Debajyoti Saha, et al.
Published: (2022-06-01)

Decreased CXCL14 expression in psoriasis recovered by narrow‐band ultraviolet B therapy
by: Kaori Nakajima, et al.
Published: (2023-12-01)

Low Vitamin D in psoriasis: Reality or myth?
by: Preethi B Nayak, et al.
Published: (2018-01-01)

The social value of a PASI 90 or PASI 100 response in patients with moderate-to-severe plaque psoriasis in Spain
by: Paulina Maravilla-Herrera, et al.
Published: (2023-01-01)

Cytokine profiles and the relationship of disease severity in patients with psoriasis
by: Qingqing Wang, et al.
Published: (2022-01-01)